Report Detail

According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012. Cardiovascular disease can be prevented by addressing behavioral risks such as obesity, cigarette smoking, and an unhealthy diet. CRT device is an implantable medical device that are used to resynchronize the contractions of the heart’s ventricles by sending tiny electrical impulses to the heart muscle, to pump the blood more efficiently.
One of the various factors that back the market growth of cardiac resynchronization therapy devices market is the expanding pool of aging and geriatric patients worldwide. That segment of the human population is more vulnerable to chronic illness and is, as such, expected to generate the immense need for these resynchronization therapy gadgets so as to facilitate and accelerate sound heart activity. Other than cardiac arrest, there are some other medical conditions like atrial fibrillation, congenital heart disease, and arrhythmias which also require the implementation and usage of these cardiac resynchronization therapy devices.
Growing prevalence of various cardiovascular diseases like cardiac arrest, sick sinus syndrome, and bradycardia are also bolstering the growth of market. To diminish the rate of mortality arising out of cardiovascular illness, many hospitals have already initiated the use of CRT-Ps for managing the failures of heart. Furthermore, many doctors are increasing the usage of surgeries that are minimally invasive (MI) for various CRT-Ps implantation. These procedures are considered safe, diminish the blood transfusion requirement. It also decreases chances of infections and reduces stay at the hospital. This eventually accelerates the recovering and process thereby leading to much improved clinical outcome. This change in inclination towards minimally invasive procedures for the purpose of CRT-Ps implantation is poised to trigger the sales of the cardiac resynchronization therapy devices in the years to come.
The North American region is expected to contribute the highest revenue over the forecast period due to rising approvals by the U.S. FDA for new products and increasing growth of geriatric population suffering from cardiac dysfunction. As of 2016, it held more 36.0% of the global market share. Europe also held a substantial share and is predicted to witness lucrative growth with CAGR of more than 7.4% over the next nine years. Higher stringency being implemented by the healthcare agencies toward R&D, safety guideline follow-up, and product approvals are expected to drive the growth.
In 2019, the market size of Cardiac Resynchronization Therapy (CRT) Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiac Resynchronization Therapy (CRT) Devices.

This report studies the global market size of Cardiac Resynchronization Therapy (CRT) Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiac Resynchronization Therapy (CRT) Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Boston Scientific
Medtronic
St. Jude Medical
Biotronik
Cook Medical
Sorin Group
...

Market Segment by Product Type
CRT-Pacemakers
CRT-Defibrillators

Market Segment by Application
Healthcare Industry
Cardiovascular industry

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Cardiac Resynchronization Therapy (CRT) Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cardiac Resynchronization Therapy (CRT) Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Cardiac Resynchronization Therapy (CRT) Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 CRT-Pacemakers
      • 1.3.3 CRT-Defibrillators
    • 1.4 Market Segment by Application
      • 1.4.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Share by Application (2019-2025)
      • 1.4.2 Healthcare Industry
      • 1.4.3 Cardiovascular industry
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Value 2014-2025
      • 2.1.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production 2014-2025
      • 2.1.3 Global Cardiac Resynchronization Therapy (CRT) Devices Capacity 2014-2025
      • 2.1.4 Global Cardiac Resynchronization Therapy (CRT) Devices Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size CAGR of Key Regions
      • 2.2.2 Global Cardiac Resynchronization Therapy (CRT) Devices Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Cardiac Resynchronization Therapy (CRT) Devices Capacity by Manufacturers
      • 3.1.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Cardiac Resynchronization Therapy (CRT) Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiac Resynchronization Therapy (CRT) Devices Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Cardiac Resynchronization Therapy (CRT) Devices Market Concentration Ratio (CR5 and HHI)
    • 3.3 Cardiac Resynchronization Therapy (CRT) Devices Price by Manufacturers
    • 3.4 Key Manufacturers Cardiac Resynchronization Therapy (CRT) Devices Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Cardiac Resynchronization Therapy (CRT) Devices Market
    • 3.6 Key Manufacturers Cardiac Resynchronization Therapy (CRT) Devices Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 CRT-Pacemakers Production and Production Value (2014-2019)
      • 4.1.2 CRT-Defibrillators Production and Production Value (2014-2019)
    • 4.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production Market Share by Type
    • 4.3 Global Cardiac Resynchronization Therapy (CRT) Devices Production Value Market Share by Type
    • 4.4 Cardiac Resynchronization Therapy (CRT) Devices Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption by Application

    6 Production by Regions

    • 6.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production (History Data) by Regions 2014-2019
    • 6.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate 2014-2019
      • 6.3.2 United States Cardiac Resynchronization Therapy (CRT) Devices Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Cardiac Resynchronization Therapy (CRT) Devices Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate 2014-2019
      • 6.4.2 European Union Cardiac Resynchronization Therapy (CRT) Devices Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Cardiac Resynchronization Therapy (CRT) Devices Import & Export
    • 6.5 China
      • 6.5.1 China Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate 2014-2019
      • 6.5.2 China Cardiac Resynchronization Therapy (CRT) Devices Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Cardiac Resynchronization Therapy (CRT) Devices Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Cardiac Resynchronization Therapy (CRT) Devices Consumption by Regions

    • 7.1 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Cardiac Resynchronization Therapy (CRT) Devices Consumption by Type
      • 7.2.2 United States Cardiac Resynchronization Therapy (CRT) Devices Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Cardiac Resynchronization Therapy (CRT) Devices Consumption by Type
      • 7.3.2 European Union Cardiac Resynchronization Therapy (CRT) Devices Consumption by Application
    • 7.4 China
      • 7.4.1 China Cardiac Resynchronization Therapy (CRT) Devices Consumption by Type
      • 7.4.2 China Cardiac Resynchronization Therapy (CRT) Devices Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Cardiac Resynchronization Therapy (CRT) Devices Consumption by Type
      • 7.5.2 Rest of World Cardiac Resynchronization Therapy (CRT) Devices Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Boston Scientific
      • 8.1.1 Boston Scientific Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.1.4 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction
      • 8.1.5 Boston Scientific Recent Development
    • 8.2 Medtronic
      • 8.2.1 Medtronic Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.2.4 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction
      • 8.2.5 Medtronic Recent Development
    • 8.3 St. Jude Medical
      • 8.3.1 St. Jude Medical Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.3.4 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction
      • 8.3.5 St. Jude Medical Recent Development
    • 8.4 Biotronik
      • 8.4.1 Biotronik Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.4.4 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction
      • 8.4.5 Biotronik Recent Development
    • 8.5 Cook Medical
      • 8.5.1 Cook Medical Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.5.4 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction
      • 8.5.5 Cook Medical Recent Development
    • 8.6 Sorin Group
      • 8.6.1 Sorin Group Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.6.4 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction
      • 8.6.5 Sorin Group Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Cardiac Resynchronization Therapy (CRT) Devices Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Forecast by Type
      • 9.7.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Cardiac Resynchronization Therapy (CRT) Devices Sales Channels
      • 10.2.2 Cardiac Resynchronization Therapy (CRT) Devices Distributors
    • 10.3 Cardiac Resynchronization Therapy (CRT) Devices Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Cardiac Resynchronization Therapy (CRT) Devices. Industry analysis & Market Report on Cardiac Resynchronization Therapy (CRT) Devices is a syndicated market report, published as Global (United States, European Union and China) Cardiac Resynchronization Therapy (CRT) Devices Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cardiac Resynchronization Therapy (CRT) Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,627.28
      3,940.92
      5,254.56
      3,063.52
      4,595.28
      6,127.04
      516,567.20
      774,850.80
      1,033,134.40
      273,519.20
      410,278.80
      547,038.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report